Clinical observation of combined transarterial chemoembolization and targeted therapy in postoperative recurrent colorectal cancer with liver metastasis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

100

Tables (1-6)

Sum=152

Publishing Process of This Article

Item

Count

Browse

Download

186

Sum=263

Aug 27, 2025 (publication date) through Aug 28, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastrointest Surg. Aug 27, 2025; 17(8): 104568
Published online Aug 27, 2025. doi: 10.4240/wjgs.v17.i8.104568

Table 3 Survival outcomes

Outcome, months	Entire cohort	Bevacizumab group	Cetuximab/panitumumab group	P value
OS	28 (24-32)	30	24	0.015
PFS	12 (10-14)	14	10	0.022

OS: Overall survival; PFS: Progression-free survival.

Citation: Liu JY, Liang ZH, Liu JL, Li L, Cui B, Li TG. Clinical observation of combined transarterial chemoembolization and targeted therapy in postoperative recurrent colorectal cancer with liver metastasis. World J Gastrointest Surg 2025; 17(8): 104568
URL: https://www.wjgnet.com/1948-9366/full/v17/i8/104568.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i8.104568